Nakao Shintaro, Kuwano Takashi, Tsutsumi-Miyahara Chikako, Ueda Shu-ichi, Kimura Yusuke N, Hamano Shinjiro, Sonoda Koh-hei, Saijo Yasuo, Nukiwa Toshihiro, Strieter Robert M, Ishibashi Tatsuro, Kuwano Michihiko, Ono Mayumi
Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Clin Invest. 2005 Nov;115(11):2979-91. doi: 10.1172/JCI23298. Epub 2005 Oct 20.
Inflammatory angiogenesis is a critical process in tumor progression and other diseases. The inflammatory cytokine IL-1beta promotes angiogenesis, tumor growth, and metastasis, but its mechanisms remain unclear. We examined the association between IL-1beta-induced angiogenesis and cell inflammation. IL-1beta induced neovascularization in the mouse cornea at rates comparable to those of VEGF. Neutrophil infiltration occurred on day 2. Macrophage infiltration occurred on days 4 and 6. The anti-Gr-1 Ab-induced depletion of infiltrating neutrophils did not affect IL-1beta- or VEGF-induced angiogenesis. The former was reduced in monocyte chemoattractant protein-1-deficient (MCP-1(-/-)) mice compared with wild-type mice. After day 4, clodronate liposomes, which kill macrophages, reduced IL-1beta-induced angiogenesis and partially inhibited VEGF-induced angiogenesis. Infiltrating macrophages near the IL-1beta-induced neovasculature were COX-2 positive. Lewis lung carcinoma cells expressing IL-1beta (LLC/IL-1beta) developed neovasculature with macrophage infiltration and enhanced tumor growth in wild-type but not MCP-1(-/-) mice. A COX-2 inhibitor reduced tumor growth, angiogenesis, and macrophage infiltration in LLC/IL-1beta. Thus, macrophage involvement might be a prerequisite for IL-1beta-induced neovascularization and tumor progression.
炎症性血管生成是肿瘤进展及其他疾病中的一个关键过程。炎性细胞因子白细胞介素-1β(IL-1β)可促进血管生成、肿瘤生长和转移,但其机制仍不清楚。我们研究了IL-1β诱导的血管生成与细胞炎症之间的关联。IL-1β在小鼠角膜中诱导新生血管形成的速率与血管内皮生长因子(VEGF)相当。中性粒细胞浸润在第2天出现。巨噬细胞浸润在第4天和第6天出现。抗Gr-1抗体诱导浸润的中性粒细胞耗竭并不影响IL-1β或VEGF诱导的血管生成。与野生型小鼠相比,单核细胞趋化蛋白-1缺陷(MCP-1(-/-))小鼠中前者减少。在第4天后,可杀死巨噬细胞的氯膦酸盐脂质体减少了IL-1β诱导的血管生成,并部分抑制了VEGF诱导的血管生成。IL-1β诱导的新生血管附近浸润的巨噬细胞COX-2呈阳性。表达IL-1β的刘易斯肺癌细胞(LLC/IL-1β)在野生型而非MCP-1(-/-)小鼠中形成了伴有巨噬细胞浸润的新生血管,并增强了肿瘤生长。一种COX-2抑制剂减少了LLC/IL-1β中的肿瘤生长、血管生成和巨噬细胞浸润。因此,巨噬细胞的参与可能是IL-1β诱导新生血管形成和肿瘤进展的一个先决条件。